We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Thales AVS France

GE Healthcare

GE Healthcare provides medical imaging and information technologies, medical diagnostics, patient monitoring systems,... read more Featured Products: More products

Download Mobile App




Events

ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.

AI-Powered Probe Aids POCUS Diagnosis and Care

By MedImaging International staff writers
Posted on 02 Sep 2021
Print article
Image: The Lexsa 128-channel linear ultrasound probe (Photo courtesy of EchoNous)
Image: The Lexsa 128-channel linear ultrasound probe (Photo courtesy of EchoNous)
A new ultrasound linear probe designed for extremity imaging assists central line placement, nerve blocks, and guides joint injections.

The EchoNous (Redmond, WA, USA) Lexsa is a new 128-channel linear probe intended for ultrasound imaging of the lungs, vasculature, nervous, and musculoskeletal systems, and is the third probe of the EchoNous artificial-intelligence (AI) powered Kosmos imaging platform. The Lexsa complements the Torso, which combines electrocardiogram (ECG), auscultation, and both continuous and pulsed wave Doppler capabilities; and the Torso-One, a slimmer version of the Torso scanner that offers only ultrasound imaging, without the additional ECG and stethoscope readings.

As its forerunners, the Lexsa connect to EchoNous’ Kosmos Bridge, which can be accessed via an Android S6 tablet--with S7 available soon--to produce high-definition (HD) image quality POCUS scans. The Kosmos Bridge, in turn, automatically saves and exports the scans to Kosmos AI, a proprietary software suite comprised of multiple AI algorithms that analyses the images, and also guides users through the scanning process with animated diagrams and automated grading and labelling.

“Lexsa will broaden the application of our Kosmos imaging platform beyond its current focus on cardiology, abdominal, and pulmonology, enabling entry into other departments that require linear capabilities for diagnosis or interventional use,” said CEO Kevin Goodwin. “Already favored for its built-in AI guidance and mapping around heart and lung structures, Kosmos will now gain traction as the ideal POCUS tool across multiple healthcare specialties.”

Hand-held POCUS systems are becoming more and more common, with new systems being offered by Butterfly Network (New York, NY, USA), Exo (Redwood City, CA, USA), and GE Healthcare (Chicago, IL, USA).

Related Links:
EchoNous
Butterfly Network
GE Healthcare



Print article
CIRS
Sun Nuclear

Channels

Imaging IT

view channel
Illustration

Global AI in Medical Diagnostics Market to Be Driven by Demand for Image Recognition in Radiology

The global artificial intelligence (AI) in medical diagnostics market is expanding with early disease detection being one of its key applications and image recognition becoming a compelling consumer proposition... Read more

Industry News

view channel
Image: GE Healthcare to be Spun Off in 2023 to Create Pure-Play Company at Center of Precision Health (Photo courtesy of GE Healthcare)

GE Healthcare to be Spun Off in 2023 to Create Pure-Play Company at Center of Precision Health

General Electric (GE; Boston, MA, USA) plans to pursue a tax-free spin-off of GE Healthcare, creating a pure-play company at the center of precision health in early 2023. The spin-off of GE Healthcare... Read more
Copyright © 2000-2021 Globetech Media. All rights reserved.